93 studies found for:    "Duchenne muscular dystrophy"
Show Display Options
Rank Status Study
21 Completed Long-term Safety, Tolerability and Efficacy of Idebenone in Duchenne Muscular Dystrophy (DELPHI Extension)
Condition: Duchenne Muscular Dystrophy
Intervention: Drug: Idebenone
22 Recruiting The PTC124 (Ataluren) Clinical Trial for Duchenne Muscular Dystrophy: Exploration of the Experiences of Parents, Clinician Researchers, and the Industry Sponsor
Condition: Duchenne Muscular Dystrophy
Intervention:
23 Unknown  Ramipril Versus Carvedilol in Duchenne and Becker Patients
Conditions: Duchenne Muscular Dystrophy;   Becker Muscular Dystrophy
Interventions: Drug: carvedilol;   Drug: ramipril
24 Completed
Has Results
Efficacy and Tolerability of Idebenone in Boys With Cardiac Dysfunction Associated With Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy (DMD)
Interventions: Drug: idebenone;   Drug: placebo
25 Recruiting Research of Biomarkers in Duchenne Muscular Dystrophy Patients
Condition: Duchenne Muscular Dystrophy (DMD)
Intervention:
26 Recruiting Tadalafil and Sildenafil for Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Interventions: Drug: Tadalafil;   Drug: Sildenafil
27 Recruiting Biomechanical Analysis of Gait in Individuals With Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Intervention:
28 Enrolling by invitation Sedation During Muscle Biopsy in Patients With Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Interventions: Drug: Ketamine;   Drug: Dexmedetomidine
29 Recruiting Finding the Optimum Regimen for Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Interventions: Drug: Prednisone;   Drug: Deflazacort
30 Completed Safety Study of Mini-dystrophin Gene to Treat Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Intervention: Biological: rAAV2.5-CMV-minidystrophin (d3990)
31 Terminated Extension Study of ACE-031 in Subjects With Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Interventions: Biological: ACE-031 (Extension of cohort 1 from core study, A031-03);   Biological: ACE-031 (Extension of cohort 2 from core study, A031-03);   Biological: ACE-031 (Extension of cohort 3 from core study, A031-03)
32 Terminated Study of ACE-031 in Subjects With Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Interventions: Biological: ACE-031 0.5 mg/kg q4wk;   Biological: ACE-031 1.0 mg/kg q2wk;   Biological: ACE-031 2.5 mg/kg q4wk;   Other: Placebo
33 Not yet recruiting Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of HT-100 in Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Intervention: Drug: HT-100
34 Recruiting Nebivolol for the Prevention of Left Ventricular Systolic Dysfunction in Patients With Duchenne Muscular Dystrophy
Conditions: Duchenne Muscular Dystrophy;   Cardiomyopathy;   Heart Failure
Interventions: Drug: Nebivolol;   Drug: Placebo
35 Unknown  This is a Study to Get More Information About Non Ambulatory Boys & Men With Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Intervention:
36 Active, not recruiting Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Intervention: Drug: AVI-4658 (Eteplirsen)
37 Completed Six Month Study of Gentamicin in Duchenne Muscular Dystrophy With Stop Codons
Condition: Duchenne Muscular Dystrophy
Intervention: Drug: Gentamicin infusions twice a week for six months
38 Active, not recruiting Phase I/II Study of PRO044 in Duchenne Muscular Dystrophy (DMD)
Condition: Duchenne Muscular Dystrophy
Interventions: Drug: PRO044 SC;   Drug: PRO044 IV
39 Recruiting A Prospective Natural History Study of Progression of Subjects With Duchenne Muscular Dystrophy.
Condition: Duchenne Muscular Dystrophy
Intervention: Other: Observational study
40 Completed Efficacy Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy Patients
Condition: Duchenne Muscular Dystrophy
Intervention: Drug: AVI-4658 (Eteplirsen)

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years